Three methods to optimise polymyxin B dosing using estimated AUC after first dose: validation with the data generated by Monte Carlo simulation.

IF 1.3 4区 医学 Q4 PHARMACOLOGY & PHARMACY
Xenobiotica Pub Date : 2024-09-01 Epub Date: 2024-07-08 DOI:10.1080/00498254.2024.2370051
Qingxia Liu, Jianxing Zhou, You Zheng, Baohua Xu, Dandan Li, Maobai Liu, Xiaohan Zhang, Xuemei Wu
{"title":"Three methods to optimise polymyxin B dosing using estimated AUC after first dose: validation with the data generated by Monte Carlo simulation.","authors":"Qingxia Liu, Jianxing Zhou, You Zheng, Baohua Xu, Dandan Li, Maobai Liu, Xiaohan Zhang, Xuemei Wu","doi":"10.1080/00498254.2024.2370051","DOIUrl":null,"url":null,"abstract":"<p><p>To achieve the AUC-guided dosing, we proposed three methods to estimate polymyxin B AUC across 24 h at steady state (AUC<sub>SS,24h</sub>) using limited concentrations after its first dose.Monte Carlo simulation based on a well-established population PK model was performed to generate the PK profiles of 1000 patients with normal or abnormal renal function. Polymyxin B AUC<sub>SS,24h</sub> was estimated for each subject using three methods (two-point PK approach, three-point PK approach, and four-point PK approach) based on limited concentration data in its first dose and compared with the actual AUC at steady state calculated using the linear-trapezoidal formula.In patients with normal renal function, the mean bias of two-point PK approach, three-point PK approach, and four-point PK approach was -8.73%, 1.37%, and -0.48%, respectively. The corresponding value was -11.15%, 1.99%, and -0.28% in patients with renal impairment, respectively. The largest mean bias of two-point PK approach, three-point PK approach, and four-point PK approach was -12.63%, -6.47%, and -0.54% when the sampling time shifted.The Excel calculators designed based on the three methods can be potentially used to optimise the dosing regimen of polymyxin B in the clinic.</p>","PeriodicalId":23812,"journal":{"name":"Xenobiotica","volume":" ","pages":"615-623"},"PeriodicalIF":1.3000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Xenobiotica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/00498254.2024.2370051","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/8 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

To achieve the AUC-guided dosing, we proposed three methods to estimate polymyxin B AUC across 24 h at steady state (AUCSS,24h) using limited concentrations after its first dose.Monte Carlo simulation based on a well-established population PK model was performed to generate the PK profiles of 1000 patients with normal or abnormal renal function. Polymyxin B AUCSS,24h was estimated for each subject using three methods (two-point PK approach, three-point PK approach, and four-point PK approach) based on limited concentration data in its first dose and compared with the actual AUC at steady state calculated using the linear-trapezoidal formula.In patients with normal renal function, the mean bias of two-point PK approach, three-point PK approach, and four-point PK approach was -8.73%, 1.37%, and -0.48%, respectively. The corresponding value was -11.15%, 1.99%, and -0.28% in patients with renal impairment, respectively. The largest mean bias of two-point PK approach, three-point PK approach, and four-point PK approach was -12.63%, -6.47%, and -0.54% when the sampling time shifted.The Excel calculators designed based on the three methods can be potentially used to optimise the dosing regimen of polymyxin B in the clinic.

利用首次用药后的估计 AUC 值优化多粘菌素 B 剂量的三种方法:利用蒙特卡洛模拟生成的数据进行验证。
目标:为了实现 AUC 指导用药,我们提出了三种方法,利用首次用药后的有限浓度估算多粘菌素 B 在稳态下 24 小时的 AUC(AUCSS,24h):为了实现AUC指导给药,我们提出了三种方法,利用首次给药后的有限浓度估算多粘菌素B在稳态下24小时的AUC(AUCSS,24h):方法:根据一个成熟的群体 PK 模型进行蒙特卡罗模拟,生成 1000 名肾功能正常或异常患者的 PK 曲线。根据首次给药后的有限浓度数据,采用三种方法(两点 PK 法、三点 PK 法和四点 PK 法)估算了每个受试者的多粘菌素 B AUCSS,24h 值,并与使用线性梯形公式计算的稳态时实际 AUC 值进行了比较。结果显示,在肾功能正常的患者中,每次取样时间的漂移对估计的 AUCSS,24h 有一定的影响:在肾功能正常的患者中,两点 PK 法、三点 PK 法和四点 PK 法的平均偏差分别为 -8.73%、1.37% 和 -0.48%。肾功能受损患者的相应数值分别为-11.15%、1.99%和-0.28%。当取样时间发生变化时,两点 PK 法、三点 PK 法和四点 PK 法的最大平均偏差分别为-12.63%、-6.47%和-0.54%。根据这些方法建立了三个用户友好、易于使用的 excel 计算器:两点 PK 法足以指导肾功能正常患者的多粘菌素 B 用药。对于肾功能不全的患者,三点 PK 法或四点 PK 法可能是更好的选择。根据这三种方法设计的 Excel 计算器可用于优化多粘菌素 B 的临床用药方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Xenobiotica
Xenobiotica 医学-毒理学
CiteScore
3.80
自引率
5.60%
发文量
96
审稿时长
2 months
期刊介绍: Xenobiotica covers seven main areas, including:General Xenobiochemistry, including in vitro studies concerned with the metabolism, disposition and excretion of drugs, and other xenobiotics, as well as the structure, function and regulation of associated enzymesClinical Pharmacokinetics and Metabolism, covering the pharmacokinetics and absorption, distribution, metabolism and excretion of drugs and other xenobiotics in manAnimal Pharmacokinetics and Metabolism, covering the pharmacokinetics, and absorption, distribution, metabolism and excretion of drugs and other xenobiotics in animalsPharmacogenetics, defined as the identification and functional characterisation of polymorphic genes that encode xenobiotic metabolising enzymes and transporters that may result in altered enzymatic, cellular and clinical responses to xenobioticsMolecular Toxicology, concerning the mechanisms of toxicity and the study of toxicology of xenobiotics at the molecular levelXenobiotic Transporters, concerned with all aspects of the carrier proteins involved in the movement of xenobiotics into and out of cells, and their impact on pharmacokinetic behaviour in animals and manTopics in Xenobiochemistry, in the form of reviews and commentaries are primarily intended to be a critical analysis of the issue, wherein the author offers opinions on the relevance of data or of a particular experimental approach or methodology
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信